Keywords: cancer, death, risk, label, regranex, food, drug

Cancer death risk label for J&J's Regranex

Article | 16 June 2008

Print This

The US Food and Drug Administration has applied an additional warning label to Regranex (becaplermin) gel, marketed by Johnson & Johnson's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in